Supriya Lifescience Limited — Board Meeting, 13-08-2025: Outcome of Board Meeting

Supriya Lifescience's board has approved the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of ₹145.07 Cr, with profit after tax at ₹34.79 Cr for the quarter. In a strategic move, the board also approved key revisions to internal governance documents. These include updates to the Nomination and Remuneration Policy, the Policy on Determination of Materiality of Events, and the Code of Conduct for Insider Trading, aiming to enhance corporate governance and compliance frameworks.